Teladoc Health granted new Chief Growth Officer, U.S. Group Health Daniel Conroy restricted stock units covering 57,034 shares and performance stock units targeting 57,034 shares, with up to 114,068 shares possible. The restricted stock units vest one-third on the first anniversary of the grant date, with the remainder vesting quarterly over the following two years, while the performance stock units are earned over three years based on financial metrics.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Teladoc Health Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603041605PRIMZONEFULLFEED9664666) on March 04, 2026, and is solely responsible for the information contained therein.